验证码已发送至您的邮箱或手机,请查收。
(Aldurazyme®) Approved
Research Code BM-101; JC-0498
CAS No.
210589-09-6
Phase III Active
Research Code EZN-2279; STM-279; rhADA; PEG-rADA
CAS No.
9026-93-1 (Adenosine deaminase)
Phase II Active
A recombinant human NaGlu potentially for the treatment of mucopolysaccharidosis IIIB.
Research Code SBC-103; rhNaGlu; 61A4G0P3IB
CAS No.
1802497-18-2
Research Code
CAS No.
134774-45-1 (Rasburicase)
Phase II Active
Research Code SHP-610; HGT-1410
CAS No.
Research Code
CAS No.
885051-90-1
Research Code
CAS No.
104138-64-9
Phase II Active
Research Code ACP-501; MEDI-6012; rhLCAT
CAS No.
Recombinant human prourokinase
(普佑克®) Approved
A recombinant human prourokinase used to treat acute myocardial infarction.
Research Code
CAS No.
Recombinant staphylokinase (Shanghai Tonghuayujin)
(施爱克®) Approved
A recombinant staphylokinase used to treat acute myocardial infarction.
Research Code
CAS No.
9040-61-3
(Elaprase®) Approved
Research Code SHP-609; GC-1111; HGT-2310; I2S; EC-3.1.6.13
CAS No.
50936-59-9
Recombinant streptokinase (Qingdao Guoda)
( 国大欣通®) Approved
A recombinant streptokinase used to treat acute myocardial infarction.
Research Code
CAS No.
9002-01-1
Recombinant human cathepsin L (Halozyme Therapeutics)
Phase II Active
A recombinant human cathepsin-L potentially for treatment of cellulite.
Research Code HTI-501; rHuCAT-L
CAS No.
Phase II Active
Research Code SEL 037; SSS-11; Uricase-PEG 20
CAS No.
1040753-26-1
(Milyzer, Tepase®) Approved
Research Code MMR-701
CAS No.
159445-63-3
Recombinant lipase (Mayoly-Spindler/AzurRx BioPharma)
Phase II Active
A yeast-derived recombinant lipase potentially for the treatment of pancreatitis.
Research Code MS-1819; MS-1819-SD
CAS No.
Research Code LT-0011; PCSOD; PCSOD-NE
CAS No.
(Brineura®) Approved
Research Code BMN-190
CAS No.
151662-36-1
(Cleactor®) Approved
Research Code E-6010; Mf-tPA
CAS No.
105913-11-9
Phase II Active
Research Code APN-01; GSK-2586881; rhACE2; 2586881
CAS No.
Successful modification
Please choose to cancel the drug